Mizuho lowered the firm’s price target on Acadia Healthcare to $70 from $84 and keeps a Neutral rating on the shares. The analyst cut estimates post the Q1 report, saying admissions trends were negatively impacted in the quarter primarily by the timing of the Easter holiday, as well as the opening of government facilities in key military specialty markets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $91 from $100 at Barclays
- Acadia Healthcare backs FY24 adjusted EPS $3.40-$3.70, consensus $3.54
- Acadia Healthcare reports Q1 adjusted EPS 84c, consensus 81c
- ACHC Upcoming Earnings Report: What to Expect?
- Acadia Healthcare upgraded to Hold from Sell at Deutsche Bank
